Long-term complications of chemotherapy for germ cell tumours

被引:101
作者
Chaudhary, UB [1 ]
Haldas, JR [1 ]
机构
[1] Med Univ S Carolina, Dept Med, Div Hematol Oncol, Charleston, SC 29425 USA
关键词
D O I
10.2165/00003495-200363150-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Testicular cancer is the most common solid tumour among young males aged 15-35 years. Cisplatin-based combination chemotherapy has changed the outlook of this disease. Disseminated testicular cancer, once uniformly fatal, now has a cure rate of more than 80% with combination chemotherapy. Systematic randomised trials have shown that cisplatin, etoposide and bleomycin (PEB) combination chemotherapy remains the mainstay of treatment. While there is a high cure rate with chemotherapy in patients with this disease, some long-term complications from chemotherapy have now been recognised, including secondary leukaemia, therapy-related solid tumours, nephrotoxicity, neurotoxicity, pulmonary toxicity, vascular toxicity and infertility. Etoposide, a DNA topoisomerase II inhibitor, is a significant risk factor for developing leukaemia; the risk appears to be correlated with the total dose given. Patients receiving cisplatin-based combination chemotherapy for testicular cancer also appear to have a higher relative risk for developing second non-germ cell malignancies; the greatest risks for therapy-related solid tumours were seen with a combination of radiation therapy plus chemotherapy. Long-term vascular toxicities associated with chemotherapy include Raynaud's phenomenon, acute myocardial infarction and cerebrovascular events. Bleomycin is thought to be the most important drug in the pathogenesis of Raynaud's phenomenon, while cisplatin is the most likely agent involved in myocardial infarction. Peripheral neuropathy is the most common form of neurotoxicity observed with cisplatin-based chemotherapy. Risk factors for the development of neural damage include a high cumulative dose of cisplatin, the use of vinblastine and the concomitant development of Raynaud's phenomenon. Cisplatin is also well known to cause significant nephrotoxicity. Approximately 25% of patients present with azoospermia after undergoing combination chemotherapy with a follow up of 2-5 years. Physician awareness of complications associated with chemotherapy is vital to maximise efficacy, minimise toxicity, and preserve quality of life after treatment. Sperm cryopreservation should be considered for patients who desire children. Close monitoring during therapy allows for the early diagnosis of complications, and close follow up of patients after the completion of therapy is necessary to monitor for relapse and development of long-term complications such as myelodysplastic syndrome and leukaemia. Despite these complications, given the potential for cure rates in this young group of patients, the benefits far outweigh the risks.
引用
收藏
页码:1565 / 1577
页数:13
相关论文
共 107 条
  • [71] Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors
    Mandanas, RA
    Saez, RA
    Epstein, RB
    Confer, DL
    Selby, GB
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 (06) : 569 - 576
  • [72] Cardiovascular morbidity in long-term survivors of metastatic testicular cancer
    Meinardi, MT
    Gietema, JA
    van der Graaf, WTA
    van Veldhuisen, DJ
    Runne, MA
    Sluiter, WJ
    de Vries, EGE
    Willemse, PBH
    Mulder, NH
    van den Berg, MP
    Koops, HS
    Sleijfer, DT
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) : 1725 - 1732
  • [73] COMPLICATIONS OF THERAPY FOR TESTICULAR CANCER
    MOUL, JW
    ROBERTSON, JE
    GEORGE, SL
    PAULSON, DF
    WALTHER, PJ
    [J]. JOURNAL OF UROLOGY, 1989, 142 (06) : 1491 - 1496
  • [74] SECONDARY LEUKEMIA ASSOCIATED WITH A CONVENTIONAL DOSE OF ETOPOSIDE - REVIEW OF SERIAL GERM-CELL TUMOR PROTOCOLS
    NICHOLS, CR
    BREEDEN, ES
    LOEHRER, PJ
    WILLIAMS, SD
    EINHORN, LH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (01) : 36 - 40
  • [75] HEMATOLOGIC NEOPLASIA ASSOCIATED WITH PRIMARY MEDIASTINAL GERM-CELL TUMORS
    NICHOLS, CR
    ROTH, BJ
    HEEREMA, N
    GRIEP, J
    TRICOT, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (20) : 1425 - 1429
  • [76] LONG-TERM EFFECTS OF CHEMOTHERAPY IN PATIENTS WITH TESTICULAR CANCER
    OSANTO, S
    BUKMAN, A
    VANHOEK, F
    STERK, PJ
    DELAAT, JAPM
    HERMANS, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) : 574 - 579
  • [77] INCREASED RISK OF MYELODYSPLASIA AND LEUKEMIA AFTER ETOPOSIDE, CISPLATIN, AND BLEOMYCIN FOR GERM-CELL TUMORS
    PEDERSENBJERGAARD, J
    DAUGAARD, G
    HANSEN, SW
    PHILIP, P
    LARSEN, SO
    RORTH, M
    [J]. LANCET, 1991, 338 (8763) : 359 - 363
  • [78] PEDERSENBJERGAARD J, 1995, LEUKEMIA LYMPHOMA, V15, P11
  • [79] Semen quality and reproductive hormones before orchiectomy in men with testicular cancer
    Petersen, PM
    Skakkebaek, NE
    Vistisen, K
    Rorth, M
    Giwercman, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 941 - 947
  • [80] ACUTE MYELOID-LEUKEMIA IN CHILDREN TREATED WITH EPIPODOPHYLLOTOXINS FOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    PUI, CH
    RIBEIRO, RC
    HANCOCK, ML
    RIVERA, GK
    EVANS, WE
    RAIMONDI, SC
    HEAD, DR
    BEHM, FG
    MAHMOUD, MH
    SANDLUND, JT
    CRIST, WM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (24) : 1682 - 1687